rozanolixizumab

Trials studying rozanolixizumab

• phase3A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravisactive not recruitingn=14
• phase1A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Womencompletedn=15
• phase3An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravisenrolling by invitationn=12
• phase4Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravisrecruitingn=40
• phase3A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravisnot yet recruitingn=120
• phase3A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)active not recruitingn=104
• phase3A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravisnot yet recruitingn=100
• phase3A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Graviscompletedn=200